BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34579056)

  • 1. Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials.
    Morales-Suarez-Varela M; Collado Sánchez E; Peraita-Costa I; Llopis-Morales A; Soriano JM
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Intermittent Fasting on Glycemic Control and Body Composition in Adults with Obesity and Type 2 Diabetes: A Systematic Review.
    Vitale R; Kim Y
    Metab Syndr Relat Disord; 2020 Dec; 18(10):450-461. PubMed ID: 32780629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Impact of Intermittent Fasting in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies.
    Borgundvaag E; Mak J; Kramer CK
    J Clin Endocrinol Metab; 2021 Mar; 106(3):902-911. PubMed ID: 33319233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health effects of intermittent fasting: hormesis or harm? A systematic review.
    Horne BD; Muhlestein JB; Anderson JL
    Am J Clin Nutr; 2015 Aug; 102(2):464-70. PubMed ID: 26135345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Intermittent Fasting as a Treatment for Type 2 Diabetes Mellitus.
    Silver DT; Pekari TB
    Med J (Ft Sam Houst Tex); 2023; (Per 23-4/5/6):65-71. PubMed ID: 37042508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes.
    Zubrzycki A; Cierpka-Kmiec K; Kmiec Z; Wronska A
    J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent Fasting: Potential Bridge of Obesity and Diabetes to Health?
    Zang BY; He LX; Xue L
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Probiotic Yogurt on Glycemic Control in Type 2 Diabetes or Obesity: A Meta-Analysis of Nine Randomized Controlled Trials.
    Barengolts E; Smith ED; Reutrakul S; Tonucci L; Anothaisintawee T
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30897796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial.
    Carter S; Clifton PM; Keogh JB
    JAMA Netw Open; 2018 Jul; 1(3):e180756. PubMed ID: 30646030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Noronha JC; Nishi SK; Braunstein CR; Khan TA; Blanco Mejia S; Kendall CWC; Kahleová H; Rahelić D; Salas-Salvadó J; Leiter LA; Sievenpiper JL
    Diabetes Care; 2019 May; 42(5):767-776. PubMed ID: 30923163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Yu Z; Nan F; Wang LY; Jiang H; Chen W; Jiang Y
    Clin Nutr; 2020 Jun; 39(6):1724-1734. PubMed ID: 31466731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
    Bahr LS; Bock M; Liebscher D; Bellmann-Strobl J; Franz L; Prüß A; Schumann D; Piper SK; Kessler CS; Steckhan N; Michalsen A; Paul F; Mähler A
    Trials; 2020 Jan; 21(1):3. PubMed ID: 31898518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of various fasting-mimicking diets among people with multiple sclerosis.
    Roman SN; Fitzgerald KC; Beier M; Mowry EM
    Mult Scler Relat Disord; 2020 Jul; 42():102149. PubMed ID: 32408153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential of fasting in type 1 diabetes.
    Varady KA; Runchey MC; Reutrakul S; Vidmar AP; Chow LS
    Trends Endocrinol Metab; 2024 May; 35(5):413-424. PubMed ID: 38331668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: a systematic review and meta-analysis.
    Schwingshackl L; Hoffmann G
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):699-706. PubMed ID: 23786819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent fasting and weight loss: Systematic review.
    Welton S; Minty R; O'Driscoll T; Willms H; Poirier D; Madden S; Kelly L
    Can Fam Physician; 2020 Feb; 66(2):117-125. PubMed ID: 32060194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials.
    Papamichou D; Panagiotakos DB; Itsiopoulos C
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):531-543. PubMed ID: 30952576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intermittent fasting on glucose and lipid metabolism.
    Antoni R; Johnston KL; Collins AL; Robertson MD
    Proc Nutr Soc; 2017 Aug; 76(3):361-368. PubMed ID: 28091348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-carbohydrate diets for the treatment of obesity and type 2 diabetes.
    Hall KD; Chung ST
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):308-312. PubMed ID: 29677013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.